{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:31:15Z","timestamp":1792794675521,"version":"4.5.0"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00428-024-03985-4","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T04:21:00Z","timestamp":1737433260000},"page":"23-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["\u201cUpdate on pediatric primary liver tumors\u201d"],"prefix":"10.1007","volume":"486","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6584-420X","authenticated-orcid":false,"given":"Dolores","family":"L\u00f3pez-Terrada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Stahlschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio R.","family":"P\u00e9rez-Atayde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"3985_CR1","unstructured":"SEER, Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Data, Incidence - SEER Research Limited-Field Data, 21 Registries 2018. Nov 2020 Sub (2000\u20132018). Accessed 18 Sept 2024"},{"issue":"1","key":"3985_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10552-022-01640-4","volume":"34","author":"P Li","year":"2023","unstructured":"Li P et al (2023) Incidence and trends of hepatic cancer among children and adolescents in the United States from 2000 to 2017: Evidence from the Surveillance, Epidemiology, and End Results registry data. Cancer Causes Control 34(1):69\u201379","journal-title":"Cancer Causes Control"},{"key":"3985_CR3","unstructured":"(2022) WHO classification of tumours editorial board. Paediatric tumours. Lyon (France): international agency f research on Cancer, 5th edn. (WHO classification of tumours series), vol 7. https:\/\/publications.iarc.fr\/608"},{"issue":"5","key":"3985_CR4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/pbc.24215","volume":"59","author":"LG Spector","year":"2012","unstructured":"Spector LG, Birch J (2012) The epidemiology of hepatoblastoma. Pediatr Blood Cancer 59(5):776\u2013779","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"3985_CR5","doi-asserted-by":"crossref","first-page":"pkz007","DOI":"10.1093\/jncics\/pkz007","volume":"3","author":"AK Hubbard","year":"2019","unstructured":"Hubbard AK et al (2019) Trends in International Incidence of Pediatric Cancers in Children Under 5 Years of Age: 1988\u20132012. JNCI Cancer Spectr 3(1):pkz007","journal-title":"JNCI Cancer Spectr"},{"issue":"Suppl 6","key":"3985_CR6","doi-asserted-by":"crossref","first-page":"e30576","DOI":"10.1002\/pbc.30576","volume":"70","author":"AF O'Neill","year":"2023","unstructured":"O\u2019Neill AF et al (2023) Children\u2019s Oncology Group\u2019s 2023 blueprint for research: Liver tumors. Pediatr Blood Cancer 70(Suppl 6):e30576","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"3985_CR7","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/modpathol.2013.80","volume":"27","author":"D Lopez-Terrada","year":"2014","unstructured":"Lopez-Terrada D et al (2014) Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol 27(3):472\u2013491","journal-title":"Mod Pathol"},{"issue":"11","key":"3985_CR8","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/pbc.25128","volume":"61","author":"LM Turcotte","year":"2014","unstructured":"Turcotte LM et al (2014) Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: a report from the Children\u2019s Oncology Group. Pediatr Blood Cancer 61(11):2018\u20132023","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"3985_CR9","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jamaoncol.2019.1215","volume":"5","author":"PJ Lupo","year":"2019","unstructured":"Lupo PJ et al (2019) Association Between Birth Defects and Cancer Risk Among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births. JAMA Oncol 5(8):1150\u20131158","journal-title":"JAMA Oncol"},{"key":"3985_CR10","unstructured":"Lopez-Terrada DH et al (2020) Chapter 31: liver tumors. In:\u00a0Helman\u00a0LJ, Blaney SM, Adamson PC (eds) Pizzo & Poplack's Pediatric Oncology, Wolters Kluwer Health: Philadelphia (PA). pp 842\u201367"},{"issue":"6","key":"3985_CR11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.humpath.2008.07.022","volume":"40","author":"D Lopez-Terrada","year":"2009","unstructured":"Lopez-Terrada D et al (2009) Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. Hum Pathol 40(6):783\u2013794","journal-title":"Hum Pathol"},{"issue":"6","key":"3985_CR12","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jhep.2014.08.009","volume":"61","author":"M Eichenmuller","year":"2014","unstructured":"Eichenmuller M et al (2014) The genomic landscape of hepatoblastoma and their progenies with HCC-like features. J Hepatol 61(6):1312\u20131320","journal-title":"J Hepatol"},{"issue":"1","key":"3985_CR13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/hep.28888","volume":"65","author":"P Sumazin","year":"2017","unstructured":"Sumazin P et al (2017) Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology 65(1):104\u2013121","journal-title":"Hepatology"},{"issue":"1","key":"3985_CR14","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1038\/s41467-021-25430-9","volume":"12","author":"G Nagae","year":"2021","unstructured":"Nagae G et al (2021) Genetic and epigenetic basis of hepatoblastoma diversity. Nat Commun 12(1):5423","journal-title":"Nat Commun"},{"issue":"4","key":"3985_CR15","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2022.04.035","volume":"77","author":"P Sumazin","year":"2022","unstructured":"Sumazin P et al (2022) Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults. J Hepatol 77(4):1026\u20131037","journal-title":"J Hepatol"},{"issue":"6","key":"3985_CR16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","volume":"14","author":"S Cairo","year":"2008","unstructured":"Cairo S et al (2008) Hepatic stem-like phenotype and interplay of Wnt\/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 14(6):471\u2013484","journal-title":"Cancer Cell"},{"issue":"2","key":"3985_CR17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jhep.2020.03.025","volume":"73","author":"J Carrillo-Reixach","year":"2020","unstructured":"Carrillo-Reixach J et al (2020) Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications. J Hepatol 73(2):328\u2013341","journal-title":"J Hepatol"},{"issue":"10","key":"3985_CR18","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1158\/2159-8290.CD-20-1809","volume":"11","author":"TZ Hirsch","year":"2021","unstructured":"Hirsch TZ et al (2021) Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer. Cancer Discov 11(10):2524\u20132543","journal-title":"Cancer Discov"},{"key":"3985_CR19","doi-asserted-by":"crossref","unstructured":"Cho SJ et al (2023) Consensus classification of pediatric hepatocellular tumors: A report from the Children's Hepatic tumors International Collaboration (CHIC).\u00a0Pediatr Blood Cancer","DOI":"10.1002\/pbc.30505"},{"issue":"12","key":"3985_CR20","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/1097-0142(20011215)92:12<3130::AID-CNCR10115>3.0.CO;2-#","volume":"92","author":"JE Haas","year":"2001","unstructured":"Haas JE, Feusner JH, Finegold MJ (2001) Small cell undifferentiated histology in hepatoblastoma may be unfavorable. Cancer 92(12):3130\u20133134","journal-title":"Cancer"},{"issue":"3","key":"3985_CR21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/pbc.21834","volume":"52","author":"AD Trobaugh-Lotrario","year":"2009","unstructured":"Trobaugh-Lotrario AD et al (2009) Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors. Pediatr Blood Cancer 52(3):328\u2013334","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"3985_CR22","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0046-8177(83)80005-7","volume":"14","author":"AG Weinberg","year":"1983","unstructured":"Weinberg AG, Finegold MJ (1983) Primary hepatic tumors of childhood. Hum Pathol 14(6):512\u2013537","journal-title":"Hum Pathol"},{"issue":"5","key":"3985_CR23","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/1097-0142(19890901)64:5<1082::AID-CNCR2820640520>3.0.CO;2-G","volume":"64","author":"JE Haas","year":"1989","unstructured":"Haas JE et al (1989) Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 64(5):1082\u20131095","journal-title":"Cancer"},{"key":"3985_CR24","unstructured":"JL D et al (2023) Protocol for the examination of resection specimens from patients with hepatoblastoma.\u00a0www.cap.org\/cancerprotocols. Accessed 18 Sept 2024"},{"key":"3985_CR25","unstructured":"L\u00f3pez-Terrada DH, A.R., Bush JW, Cho S, de Krijger RR, Inoue T, O\u2019Neill AF, Perez-Atayde A, Ranganathan S, Stahlschmidt J, Tanaka Y, Cohen M, Reyes-M\u00fagica M, Hepatoblastoma Histopathology Reporting Guide (2023), International Collaboration on Cancer Reporting: Sydney, Australia. p. 38\u20132"},{"issue":"2","key":"3985_CR26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1093526619875228","volume":"23","author":"S Ranganathan","year":"2020","unstructured":"Ranganathan S, Lopez-Terrada D, Alaggio R (2020) Hepatoblastoma and Pediatric Hepatocellular Carcinoma: An Update. Pediatr Dev Pathol 23(2):79\u201395","journal-title":"Pediatr Dev Pathol"},{"issue":"5","key":"3985_CR27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1200\/JCO.21.00803","volume":"40","author":"A Trobaugh-Lotrario","year":"2022","unstructured":"Trobaugh-Lotrario A et al (2022) Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children\u2019s Oncology Group (COG) AHEP0731 Study Committee. J Clin Oncol 40(5):459\u2013467","journal-title":"J Clin Oncol"},{"issue":"5","key":"3985_CR28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/mpo.10173","volume":"39","author":"A Zimmermann","year":"2002","unstructured":"Zimmermann A (2002) Hepatoblastoma with cholangioblastic features ('cholangioblastic hepatoblastoma\u2019) and other liver tumors with bimodal differentiation in young patients. Med Pediatr Oncol 39(5):487\u2013491","journal-title":"Med Pediatr Oncol"},{"issue":"11","key":"3985_CR29","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/1097-0142(19860601)57:11<2168::AID-CNCR2820571115>3.0.CO;2-M","volume":"57","author":"C Manivel","year":"1986","unstructured":"Manivel C et al (1986) Teratoid hepatoblastoma. The nosologic dilemma of solid embryonic neoplasms of childhood. Cancer 57(11):2168\u201374","journal-title":"Cancer"},{"issue":"7","key":"3985_CR30","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00000478-198210000-00002","volume":"6","author":"F Gonzalez-Crussi","year":"1982","unstructured":"Gonzalez-Crussi F, Upton MP, Maurer HS (1982) Hepatoblastoma. Attempt at characterization of histologic subtypes. Am J Surg Pathol 6(7):599\u2013612","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"3985_CR31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/PAS.0b013e3181ce5f1e","volume":"34","author":"LL Wang","year":"2010","unstructured":"Wang LL et al (2010) Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study. Am J Surg Pathol 34(3):287\u2013299","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"3985_CR32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/modpathol.2008.85","volume":"21","author":"N Shafizadeh","year":"2008","unstructured":"Shafizadeh N, Ferrell LD, Kakar S (2008) Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum. Mod Pathol 21(8):1011\u20131018","journal-title":"Mod Pathol"},{"issue":"12","key":"3985_CR33","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/00000478-199312000-00008","volume":"17","author":"R Saxena","year":"1993","unstructured":"Saxena R et al (1993) Chemotherapy effects on hepatoblastoma. A histological study. Am J Surg Pathol 17(12):1266\u201371","journal-title":"Am J Surg Pathol"},{"key":"3985_CR34","unstructured":"SEER, Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Data, Incidence - SEER Research Limited-Field Data, 21 Registries 2018. 2020. Nov 2020 Sub (2000\u20132018). Accessed 18 Sept 2024"},{"issue":"12","key":"3985_CR35","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2002.06.102","volume":"20","author":"P Czauderna","year":"2002","unstructured":"Czauderna P et al (2002) Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol 20(12):2798\u20132804","journal-title":"J Clin Oncol"},{"key":"3985_CR36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/JHC.S94008","volume":"4","author":"I Schmid","year":"2017","unstructured":"Schmid I, von Schweinitz D (2017) Pediatric hepatocellular carcinoma: challenges and solutions. J Hepatocell Carcinoma 4:15\u201321","journal-title":"J Hepatocell Carcinoma"},{"key":"3985_CR37","doi-asserted-by":"crossref","unstructured":"Hadzic, N et al (2011) Hepatocellular carcinoma in biliary atresia: King's College Hospital experience. J Pediatr 159(4) 617\u201322 e1","DOI":"10.1016\/j.jpeds.2011.03.004"},{"issue":"3","key":"3985_CR38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.path.2010.06.006","volume":"3","author":"A Roy","year":"2010","unstructured":"Roy A, Finegold MJ (2010) Biopsy Diagnosis of Inherited Liver Disease. Surg Pathol Clin 3(3):743\u2013768","journal-title":"Surg Pathol Clin"},{"issue":"10","key":"3985_CR39","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD et al (2019) A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 16(10):589\u2013604","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"3985_CR40","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/1097-0142(20010715)92:2<332::AID-CNCR1327>3.0.CO;2-3","volume":"92","author":"LK Su","year":"2001","unstructured":"Su LK et al (2001) Biallelic inactivation of the APC gene is associated with hepatocellular carcinoma in familial adenomatous polyposis coli. Cancer 92(2):332\u2013339","journal-title":"Cancer"},{"key":"3985_CR41","unstructured":"Schneider K, Zelley K, Nichols KE et al (1999) Li-Fraumeni Syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (eds) In GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle"},{"issue":"7","key":"3985_CR42","doi-asserted-by":"crossref","first-page":"e27745","DOI":"10.1002\/pbc.27745","volume":"66","author":"K Haines","year":"2019","unstructured":"Haines K et al (2019) Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation. Pediatr Blood Cancer 66(7):e27745","journal-title":"Pediatr Blood Cancer"},{"key":"3985_CR43","doi-asserted-by":"crossref","unstructured":"Zucman-Rossi, J., et al (2015) Genetic Landscape and Biomarkers of Hepatocellular Carcinoma. Gastroenterology 149(5): 1226\u20131239 e4.","DOI":"10.1053\/j.gastro.2015.05.061"},{"issue":"8","key":"3985_CR44","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/cncr.11292","volume":"97","author":"HM Katzenstein","year":"2003","unstructured":"Katzenstein HM et al (2003) Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 97(8):2006\u20132012","journal-title":"Cancer"},{"issue":"2","key":"3985_CR45","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/1097-0142(19800715)46:2<372::AID-CNCR2820460227>3.0.CO;2-S","volume":"46","author":"JR Craig","year":"1980","unstructured":"Craig JR et al (1980) Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 46(2):372\u2013379","journal-title":"Cancer"},{"issue":"9","key":"3985_CR46","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/modpathol.2010.105","volume":"23","author":"SC Ward","year":"2010","unstructured":"Ward SC et al (2010) Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation. Mod Pathol 23(9):1180\u20131190","journal-title":"Mod Pathol"},{"issue":"3","key":"3985_CR47","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/modpathol.2010.207","volume":"24","author":"HM Ross","year":"2011","unstructured":"Ross HM et al (2011) Fibrolamellar carcinomas are positive for CD68. Mod Pathol 24(3):390\u2013395","journal-title":"Mod Pathol"},{"issue":"6174","key":"3985_CR48","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1249484","volume":"343","author":"JN Honeyman","year":"2014","unstructured":"Honeyman JN et al (2014) Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. Science 343(6174):1010\u20131014","journal-title":"Science"},{"issue":"4","key":"3985_CR49","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41379-019-0398-2","volume":"33","author":"M Vyas","year":"2020","unstructured":"Vyas M et al (2020) DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma. Mod Pathol 33(4):648\u2013656","journal-title":"Mod Pathol"},{"issue":"5","key":"3985_CR50","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jhep.2019.12.006","volume":"72","author":"TZ Hirsch","year":"2020","unstructured":"Hirsch TZ et al (2020) BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA. J Hepatol 72(5):924\u2013936","journal-title":"J Hepatol"},{"issue":"4","key":"3985_CR51","doi-asserted-by":"crossref","first-page":"100770","DOI":"10.1016\/j.currproblcancer.2021.100770","volume":"45","author":"AF O'Neill","year":"2021","unstructured":"O\u2019Neill AF et al (2021) Fibrolamellar carcinoma: An entity all its own. Curr Probl Cancer 45(4):100770","journal-title":"Curr Probl Cancer"},{"issue":"2","key":"3985_CR52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/10935266231204788","volume":"27","author":"Y Chen Wongworawat","year":"2024","unstructured":"Chen Wongworawat Y et al (2024) Molecular Profiling of a Hepatocellular Neoplasm Not Otherwise Specified (HCN-NOS) Demonstrates Distinct Molecular Features in Hepatoblastoma and HCC-Like Components. Pediatr Dev Pathol 27(2):169\u2013175","journal-title":"Pediatr Dev Pathol"},{"issue":"3","key":"3985_CR53","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1210\/jc.2003-031552","volume":"89","author":"Y Reznik","year":"2004","unstructured":"Reznik Y et al (2004) Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families. J Clin Endocrinol Metab 89(3):1476\u20131480","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"3985_CR54","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.3748\/wjg.v26.i19.2294","volume":"26","author":"E Hahn","year":"2020","unstructured":"Hahn E, Putra J (2020) Hepatocellular adenoma in the paediatric population: Molecular classification and clinical associations. World J Gastroenterol 26(19):2294\u20132304","journal-title":"World J Gastroenterol"},{"issue":"7","key":"3985_CR55","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/liv.14547","volume":"40","author":"AJ Klompenhouwer","year":"2020","unstructured":"Klompenhouwer AJ et al (2020) New insights in the management of Hepatocellular Adenoma. Liver Int 40(7):1529\u20131537","journal-title":"Liver Int"},{"issue":"12","key":"3985_CR56","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1097\/PAS.0000000000001763","volume":"45","author":"MC Pacheco","year":"2021","unstructured":"Pacheco MC et al (2021) Pediatric Hepatocellular Adenomas: The Influence of Age and Syndrome on Subtype. Am J Surg Pathol 45(12):1641\u20131647","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"3985_CR57","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/hep.21743","volume":"46","author":"P Bioulac-Sage","year":"2007","unstructured":"Bioulac-Sage P et al (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46(3):740\u2013748","journal-title":"Hepatology"},{"key":"3985_CR58","doi-asserted-by":"crossref","unstructured":"Espinoza AF et al (2023) Pediatric Hepatocellular Adenomas: What Is Known and What Is New? Cancers (Basel). 2023 Sep 29;15(19):4790.","DOI":"10.3390\/cancers15194790"},{"issue":"8","key":"3985_CR59","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1478-3231.2012.02786.x","volume":"32","author":"P Bioulac-Sage","year":"2012","unstructured":"Bioulac-Sage P et al (2012) Hepatocellular adenoma subtypes: the impact of overweight and obesity. Liver Int 32(8):1217\u20131221","journal-title":"Liver Int"},{"issue":"5","key":"3985_CR60","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jhep.2017.07.009","volume":"67","author":"JC Nault","year":"2017","unstructured":"Nault JC et al (2017) Molecular classification of hepatocellular adenoma in clinical practice. J Hepatol 67(5):1074\u20131083","journal-title":"J Hepatol"},{"issue":"7226","key":"3985_CR61","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature07475","volume":"457","author":"S Rebouissou","year":"2009","unstructured":"Rebouissou S et al (2009) Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 457(7226):200\u2013204","journal-title":"Nature"},{"issue":"11","key":"3985_CR62","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.jpedsurg.2007.07.047","volume":"42","author":"H Isaacs Jr","year":"2007","unstructured":"Isaacs H Jr (2007) Fetal and neonatal hepatic tumors. J Pediatr Surg 42(11):1797\u20131803","journal-title":"J Pediatr Surg"},{"key":"3985_CR63","doi-asserted-by":"crossref","unstructured":"Christison-Lagay, E.R., et al., Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg, 2007. 42(1): p. 62\u20137; discussion 67\u20138","DOI":"10.1016\/j.jpedsurg.2006.09.041"},{"key":"3985_CR64","doi-asserted-by":"crossref","unstructured":"Lewis D et al (2018) Rapidly involuting congenital haemangioma of the liver. BMJ Case Rep","DOI":"10.1136\/bcr-2018-224337"},{"issue":"1","key":"3985_CR65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0046-8177(00)80192-6","volume":"31","author":"PE North","year":"2000","unstructured":"North PE et al (2000) GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 31(1):11\u201322","journal-title":"Hum Pathol"},{"issue":"6","key":"3985_CR66","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10024-003-2134-6","volume":"6","author":"B Berenguer","year":"2003","unstructured":"Berenguer B et al (2003) Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol 6(6):495\u2013510","journal-title":"Pediatr Dev Pathol"},{"issue":"6","key":"3985_CR67","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.ajhg.2016.05.010","volume":"98","author":"UM Ayturk","year":"2016","unstructured":"Ayturk UM et al (2016) Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma. Am J Hum Genet 98(6):1271","journal-title":"Am J Hum Genet"},{"issue":"8","key":"3985_CR68","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/gim.2017.200","volume":"20","author":"L Rodriguez-Laguna","year":"2018","unstructured":"Rodriguez-Laguna L et al (2018) CLAPO syndrome: identification of somatic activating PIK3CA mutations and delineation of the natural history and phenotype. Genet Med 20(8):882\u2013889","journal-title":"Genet Med"},{"issue":"1","key":"3985_CR69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jpedsurg.2008.10.021","volume":"44","author":"B Dickie","year":"2009","unstructured":"Dickie B et al (2009) Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg 44(1):125\u2013133","journal-title":"J Pediatr Surg"},{"key":"3985_CR70","doi-asserted-by":"crossref","unstructured":"Hettmer S et al (2017) Epithelioid hemangioendotheliomas of the liver and lung in children and adolescents. Pediatr Blood Cancer 64(12)","DOI":"10.1002\/pbc.26675"},{"issue":"1","key":"3985_CR71","first-page":"82","volume":"7","author":"M Miettinen","year":"1994","unstructured":"Miettinen M, Lindenmayer AE, Chaubal A (1994) Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens\u2013evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 7(1):82\u201390","journal-title":"Mod Pathol"},{"issue":"1","key":"3985_CR72","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/01.pas.0000178088.69394.7b","volume":"30","author":"AT Deyrup","year":"2006","unstructured":"Deyrup AT et al (2006) Epstein-Barr virus-associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events: a clinicopathologic and molecular analysis of 29 tumors from 19 patients. Am J Surg Pathol 30(1):75\u201382","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"3985_CR73","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4251\/wjgo.v13.i4.223","volume":"13","author":"S Bannoura","year":"2021","unstructured":"Bannoura S, Putra J (2021) Primary malignant vascular tumors of the liver in children: Angiosarcoma and epithelioid hemangioendothelioma. World J Gastrointest Oncol 13(4):223\u2013230","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"3985_CR74","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF00972043","volume":"11","author":"SG Kirchner","year":"1981","unstructured":"Kirchner SG et al (1981) Infantile hepatic hemangioendothelioma with subsequent malignant degeneration. Pediatr Radiol 11(1):42\u201345","journal-title":"Pediatr Radiol"},{"issue":"6","key":"3985_CR75","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MPG.0b013e318230146c","volume":"53","author":"O Ackermann","year":"2011","unstructured":"Ackermann O et al (2011) Widening spectrum of liver angiosarcoma in children. J Pediatr Gastroenterol Nutr 53(6):615\u2013619","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"3985_CR76","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00000478-200403000-00002","volume":"28","author":"KH Allison","year":"2004","unstructured":"Allison KH et al (2004) Angiosarcoma involving the gastrointestinal tract: a series of primary and metastatic cases. Am J Surg Pathol 28(3):298\u2013307","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"3985_CR77","doi-asserted-by":"crossref","first-page":"e26272","DOI":"10.1002\/pbc.26272","volume":"64","author":"Y Shi","year":"2017","unstructured":"Shi Y et al (2017) 2017 Characteristics and outcomes in children with undifferentiated embryonal sarcoma of the liver: a report from the national cancer database. Pediatr Blood Cancer 64(4):e26272","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"3985_CR78","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.humpath.2011.06.016","volume":"43","author":"M Levy","year":"2012","unstructured":"Levy M et al (2012) Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver. Hum Pathol 43(5):695\u2013701","journal-title":"Hum Pathol"},{"issue":"2","key":"3985_CR79","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5858\/arpa.2013-0463-RS","volume":"139","author":"J Putra","year":"2015","unstructured":"Putra J, Ornvold K (2015) Undifferentiated embryonal sarcoma of the liver: a concise review. Arch Pathol Lab Med 139(2):269\u2013273","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"3985_CR80","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.5858\/2006-130-1567-HMHASR","volume":"130","author":"MA Siddiqui","year":"2006","unstructured":"Siddiqui MA, McKenna BJ (2006) Hepatic mesenchymal hamartoma: a short review. Arch Pathol Lab Med 130(10):1567\u20131569","journal-title":"Arch Pathol Lab Med"},{"key":"3985_CR81","doi-asserted-by":"crossref","unstructured":"Martins-Filho SN, Putra J (2020) Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review. Hepat Oncol 7(2):HEP19","DOI":"10.2217\/hep-2020-0002"},{"issue":"4","key":"3985_CR82","doi-asserted-by":"crossref","first-page":"e1008642","DOI":"10.1371\/journal.pgen.1008642","volume":"16","author":"BA Setty","year":"2020","unstructured":"Setty BA et al (2020) The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss. PLoS Genet 16(4):e1008642","journal-title":"PLoS Genet"},{"issue":"12","key":"3985_CR83","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.3390\/cancers11121992","volume":"11","author":"L Fazlollahi","year":"2019","unstructured":"Fazlollahi L et al (2019) Malignant Rhabdoid tumor, an aggressive tumor often misclassified as small cell variant of hepatoblastoma. Cancers (Basel) 11(12):1992","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3985_CR84","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12876-022-02102-6","volume":"22","author":"H Ye","year":"2022","unstructured":"Ye H, Liu Z, Zhang Y (2022) Malignant rhabdoid tumor of the liver in a middle-aged woman: a case report and literature review. BMC Gastroenterol 22(1):28","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"3985_CR85","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.radcr.2018.03.017","volume":"13","author":"N Kapral","year":"2018","unstructured":"Kapral N et al (2018) Pediatric hepatic rhabdoid tumor: A rare cause of abdominal mass in children. Radiol Case Rep 13(3):724\u2013727","journal-title":"Radiol Case Rep"},{"issue":"1","key":"3985_CR86","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.4081\/pr.2015.5578","volume":"7","author":"S Oita","year":"2015","unstructured":"Oita S et al (2015) Malignant rhabdoid tumor of the liver: a case report and literature review. Pediatr Rep 7(1):5578","journal-title":"Pediatr Rep"},{"issue":"10","key":"3985_CR87","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/modpathol.2016.106","volume":"29","author":"K Kohashi","year":"2016","unstructured":"Kohashi K et al (2016) Reclassification of rhabdoid tumor and pediatric undifferentiated\/unclassified sarcoma with complete loss of SMARCB1\/INI1 protein expression: three subtypes of rhabdoid tumor according to their histological features. Mod Pathol 29(10):1232\u20131242","journal-title":"Mod Pathol"},{"issue":"3","key":"3985_CR88","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/gcc.23010","volume":"61","author":"NP Agaram","year":"2022","unstructured":"Agaram NP et al (2022) Clinicopathologic and survival correlates of embryonal rhabdomyosarcoma driven by RAS\/RAF mutations. Genes Chromosomes Cancer 61(3):131\u2013137","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"3985_CR89","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s002470050305","volume":"28","author":"DJ Roebuck","year":"1998","unstructured":"Roebuck DJ et al (1998) Hepatobiliary rhabdomyosarcoma in children: diagnostic radiology. Pediatr Radiol 28(2):101\u2013108","journal-title":"Pediatr Radiol"},{"issue":"20","key":"3985_CR90","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1200\/JCO.2008.19.7483","volume":"27","author":"I Sultan","year":"2009","unstructured":"Sultan I et al (2009) Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol 27(20):3391\u20133397","journal-title":"J Clin Oncol"},{"key":"3985_CR91","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.701400","volume":"11","author":"J Fuchs","year":"2021","unstructured":"Fuchs J et al (2021) Biliary Rhabdomyosarcoma in Pediatric Patients: A Systematic Review and Meta-Analysis of Individual Patient Data. Front Oncol 11:701400","journal-title":"Front Oncol"},{"issue":"6","key":"3985_CR92","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/PAP.0b013e3182a92d0d","volume":"20","author":"DM Parham","year":"2013","unstructured":"Parham DM, Barr FG (2013) Classification of rhabdomyosarcoma and its molecular basis. Adv Anat Pathol 20(6):387\u2013397","journal-title":"Adv Anat Pathol"},{"issue":"26","key":"3985_CR93","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1200\/JCO.20.03060","volume":"39","author":"JF Shern","year":"2021","unstructured":"Shern JF et al (2021) Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium. J Clin Oncol 39(26):2859\u20132871","journal-title":"J Clin Oncol"},{"issue":"11","key":"3985_CR94","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.jpedsurg.2005.07.052","volume":"40","author":"MD Stringer","year":"2005","unstructured":"Stringer MD, Alizai NK (2005) Mesenchymal hamartoma of the liver: a systematic review. J Pediatr Surg 40(11):1681\u20131690","journal-title":"J Pediatr Surg"},{"issue":"2","key":"3985_CR95","first-page":"230","volume":"48","author":"S Rao","year":"2022","unstructured":"Rao S et al (2022) Pediatric Mesenchymal Hamartoma of Liver: A Case Report with Histomorphological Differential Diagnosis and Review of Literature. Curr Health Sci J 48(2):230\u2013234","journal-title":"Curr Health Sci J"},{"key":"3985_CR96","doi-asserted-by":"crossref","first-page":"102324","DOI":"10.1016\/j.epsc.2022.102324","volume":"84","author":"J Bauzon","year":"2022","unstructured":"Bauzon J et al (2022) A rapidly growing mesenchymal hamartoma in a neonate with known placental anomalies. J Pediatr Surg Case Rep 84:102324","journal-title":"J Pediatr Surg Case Rep"},{"issue":"6","key":"3985_CR97","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1056\/NEJMc1905439","volume":"381","author":"VH Nguyen","year":"2019","unstructured":"Nguyen VH, Bouron-Dal Soglio D, Foulkes WD (2019) Mesenchymal Hamartoma of the Liver and DICER1 Syndrome. Reply N Engl J Med 381(6):587","journal-title":"Reply N Engl J Med"},{"issue":"6","key":"3985_CR98","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMc1907523","volume":"381","author":"SO Vargas","year":"2019","unstructured":"Vargas SO, Perez-Atayde AR (2019) Mesenchymal Hamartoma of the Liver and DICER1 Syndrome. N Engl J Med 381(6):586\u2013587","journal-title":"N Engl J Med"},{"issue":"19","key":"3985_CR99","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1812169","volume":"380","author":"M Apellaniz-Ruiz","year":"2019","unstructured":"Apellaniz-Ruiz M et al (2019) Mesenchymal Hamartoma of the Liver and DICER1 Syndrome. N Engl J Med 380(19):1834\u20131842","journal-title":"N Engl J Med"},{"issue":"12","key":"3985_CR100","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1097\/01.pas.0000173232.22117.37","volume":"29","author":"AL Folpe","year":"2005","unstructured":"Folpe AL et al (2005) Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol 29(12):1558\u20131575","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"3985_CR101","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.jpedsurg.2012.02.023","volume":"47","author":"R Alaggio","year":"2012","unstructured":"Alaggio R et al (2012) Malignant perivascular epithelioid cell tumor in children: description of a case and review of the literature. J Pediatr Surg 47(6):e31-40","journal-title":"J Pediatr Surg"},{"issue":"1","key":"3985_CR102","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12032-012-0416-4","volume":"30","author":"X Yang","year":"2013","unstructured":"Yang X, Li A, Wu M (2013) Hepatic angiomyolipoma: clinical, imaging and pathological features in 178 cases. Med Oncol 30(1):416","journal-title":"Med Oncol"},{"issue":"5","key":"3985_CR103","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/PAS.0b013e31824a8a37","volume":"36","author":"I Malinowska","year":"2012","unstructured":"Malinowska I et al (2012) Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: further evidence for a biological distinction. Am J Surg Pathol 36(5):783\u2013784","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"3985_CR104","doi-asserted-by":"crossref","first-page":"e236288","DOI":"10.1136\/bcr-2020-236288","volume":"13","author":"M Janks","year":"2020","unstructured":"Janks M et al (2020) Hepatic perivascular epithelioid cell tumours in children with tuberous sclerosis. BMJ Case Rep 13(12):e236288","journal-title":"BMJ Case Rep"},{"issue":"10","key":"3985_CR105","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/PAS.0b013e3181f17ac0","volume":"34","author":"P Argani","year":"2010","unstructured":"Argani P et al (2010) A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol 34(10):1395\u20131406","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"3985_CR106","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-0036-1584319","volume":"36","author":"Y Zen","year":"2016","unstructured":"Zen Y (2016) The Pathology of IgG4-Related Disease in the Bile Duct and Pancreas. Semin Liver Dis 36(3):242\u2013256","journal-title":"Semin Liver Dis"},{"issue":"3","key":"3985_CR107","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.path.2023.04.010","volume":"16","author":"D Wang","year":"2023","unstructured":"Wang D, Misdraji J (2023) Inflammatory Pseudotumor of the Liver. Surg Pathol Clin 16(3):565\u2013580","journal-title":"Surg Pathol Clin"},{"key":"3985_CR108","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.4076\/1757-1626-2-7029","volume":"2","author":"I Naitoh","year":"2009","unstructured":"Naitoh I et al (2009) IgG4-related hepatic inflammatory pseudotumor with sclerosing cholangitis: a case report and review of the literature. Cases J 2:7029","journal-title":"Cases J"},{"issue":"1","key":"3985_CR109","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/cncr.24684","volume":"116","author":"R Alaggio","year":"2010","unstructured":"Alaggio R et al (2010) Inflammatory myofibroblastic tumors in childhood: a report from the Italian Cooperative Group studies. Cancer 116(1):216\u2013226","journal-title":"Cancer"},{"issue":"4","key":"3985_CR110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/01.pas.0000213393.57322.c7","volume":"31","author":"CM Coffin","year":"2007","unstructured":"Coffin CM, Hornick JL, Fletcher CD (2007) Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 31(4):509\u2013520","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"3985_CR111","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00000478-200106000-00007","volume":"25","author":"JK Chan","year":"2001","unstructured":"Chan JK, Cheuk W, Shimizu M (2001) Anaplastic lymphoma kinase expression in inflammatory pseudotumors. Am J Surg Pathol 25(6):761\u2013768","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"3985_CR112","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/00000478-200111000-00003","volume":"25","author":"JR Cook","year":"2001","unstructured":"Cook JR et al (2001) Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol 25(11):1364\u20131371","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"3985_CR113","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/PAS.0000000000000404","volume":"39","author":"CR Antonescu","year":"2015","unstructured":"Antonescu CR et al (2015) Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement. Am J Surg Pathol 39(7):957\u2013967","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"3985_CR114","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/PAS.0000000000000677","volume":"40","author":"AH Alassiri","year":"2016","unstructured":"Alassiri AH et al (2016) ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors. Am J Surg Pathol 40(8):1051\u20131061","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"3985_CR115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/his.12910","volume":"69","author":"H Yamamoto","year":"2016","unstructured":"Yamamoto H et al (2016) ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours. Histopathology 69(1):72\u201383","journal-title":"Histopathology"},{"issue":"8","key":"3985_CR116","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/2159-8290.CD-14-0377","volume":"4","author":"CM Lovly","year":"2014","unstructured":"Lovly CM et al (2014) Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. Cancer Discov 4(8):889\u2013895","journal-title":"Cancer Discov"},{"issue":"1","key":"3985_CR117","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.pas.0000147398.03015.9e","volume":"29","author":"A Heerema-McKenney","year":"2005","unstructured":"Heerema-McKenney A et al (2005) Nested stromal epithelial tumor of the liver: six cases of a distinctive pediatric neoplasm with frequent calcifications and association with cushing syndrome. Am J Surg Pathol 29(1):10\u201320","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"3985_CR118","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2350\/13-02-1300-CR.1","volume":"16","author":"JI Malowany","year":"2013","unstructured":"Malowany JI et al (2013) Nested stromal epithelial tumor of the liver in Beckwith-Wiedemann syndrome. Pediatr Dev Pathol 16(4):312\u2013317","journal-title":"Pediatr Dev Pathol"},{"issue":"7","key":"3985_CR119","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/PAS.0b013e31819c1ab3","volume":"33","author":"HR Makhlouf","year":"2009","unstructured":"Makhlouf HR et al (2009) Calcifying nested stromal-epithelial tumors of the liver: a clinicopathologic, immunohistochemical, and molecular genetic study of 9 cases with a long-term follow-up. Am J Surg Pathol 33(7):976\u2013983","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"3985_CR120","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.humpath.2012.03.018","volume":"43","author":"G Assmann","year":"2012","unstructured":"Assmann G et al (2012) beta-Catenin mutations in 2 nested stromal epithelial tumors of the liver\u2013a neoplasia with defective mesenchymal-epithelial transition. Hum Pathol 43(11):1815\u20131827","journal-title":"Hum Pathol"},{"issue":"9","key":"3985_CR121","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/s41379-021-00822-w","volume":"34","author":"DJ Papke Jr","year":"2021","unstructured":"Papke DJ Jr et al (2021) Calcifying nested stromal-epithelial tumor: a clinicopathologic and molecular genetic study of eight cases highlighting metastatic potential and recurrent CTNNB1 and TERT promoter alterations. Mod Pathol 34(9):1696\u20131703","journal-title":"Mod Pathol"},{"key":"3985_CR122","doi-asserted-by":"crossref","first-page":"859407","DOI":"10.1155\/2008\/859407","volume":"2008","author":"K Moore Dalal","year":"2008","unstructured":"Moore Dalal K et al (2008) EBV-Associated Smooth Muscle Neoplasms: Solid Tumors Arising in the Presence of Immunosuppression and Autoimmune Diseases. Sarcoma 2008:859407","journal-title":"Sarcoma"},{"key":"3985_CR123","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fimmu.2018.00368","volume":"9","author":"T Magg","year":"2018","unstructured":"Magg T et al (2018) Epstein-Barr Virus(+) Smooth Muscle Tumors as Manifestation of Primary Immunodeficiency Disorders. Front Immunol 9:368","journal-title":"Front Immunol"},{"issue":"1","key":"3985_CR124","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/cid\/ciw160","volume":"63","author":"JI Cohen","year":"2016","unstructured":"Cohen JI et al (2016) Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers. Clin Infect Dis 63(1):41\u201347","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3985_CR125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/00313020220131309","volume":"34","author":"W Cheuk","year":"2002","unstructured":"Cheuk W, Li PC, Chan JK (2002) Epstein-Barr virus-associated smooth muscle tumour: a distinctive mesenchymal tumour of immunocompromised individuals. Pathology 34(3):245\u2013249","journal-title":"Pathology"},{"issue":"3","key":"3985_CR126","doi-asserted-by":"crossref","first-page":"e13384","DOI":"10.1111\/petr.13384","volume":"23","author":"KE Ocwieja","year":"2019","unstructured":"Ocwieja KE et al (2019) Pediatric post-transplant hepatic kaposi sarcoma due to donor-derived human herpesvirus 8. Pediatr Transplant 23(3):e13384","journal-title":"Pediatr Transplant"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03985-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-024-03985-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03985-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T06:32:05Z","timestamp":1738218725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-024-03985-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":126,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3985"],"URL":"https:\/\/doi.org\/10.1007\/s00428-024-03985-4","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript was prepared in compliance with the Ethical Standards of the journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare they have no financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}